Summit Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
ZANGANEH MAHKAM director, officer: Chief Execut..
Common Stock 34,321 $3.72 $127,674
Purchase
ZANGANEH MAHKAM director, officer: Chief Execut..
Common Stock 26,000 $3.72 $96,720
Purchase
ZANGANEH MAHKAM director, officer: Chief Execut..
Common Stock 20,000 $3.71 $74,200
Purchase
ZANGANEH MAHKAM director, officer: Chief Execut..
Common Stock 30,000 $3.75 $112,500
Purchase
DHINGRA ANKUR officer: Chief Financial Officer
Common Stock 100,000 $3.75 $375,000
Purchase
DHINGRA ANKUR officer: Chief Financial Officer
Common Stock 19,700 $2.17 $42,749
Purchase
DHINGRA ANKUR officer: Chief Financial Officer
Common Stock 700 $2.15 $1,505
Purchase
SONI MANMEET SINGH director, officer: Chief Operat..
Common Stock 2,976,190 $1.68 $4,999,999
Purchase
ZANGANEH MAHKAM director, officer: Co-CEO & Pre..
Common Stock 13,497,258 $1.05 $14,172,121
Purchase
ZANGANEH MAHKAM director, officer: Co-Chief Exe..
Common Stock 804,672 $1.05 $844,906
Purchase
ZANGANEH MAHKAM director, officer: Co-Chief Exe..
Common Stock 15,973,743 $1.05 $16,772,430
Purchase
ZANGANEH MAHKAM director, officer: Co-CEO & Pre..
Common Stock 16,778,415 $1.05 $17,617,336
Purchase
DHINGRA ANKUR officer: Chief Financial Officer
Common Stock 196,362 $1.05 $206,180
Purchase
DUGGAN ROBERT W director, officer: Chief Execut..
Common Stock 376,489,880 $1.05 $395,314,374
Purchase
DHINGRA ANKUR officer: Chief Financial Officer
Common Stock 11,557 $0.97 $11,210
Purchase
DHINGRA ANKUR officer: Chief Financial Officer
Common Stock 24,658 $0.97 $23,918
Purchase
ZANGANEH MAKY director, officer: Co-CEO & Pre..
Common Stock 4,593,777 $0.97 $4,455,964
Purchase
ZANGANEH MAKY director, officer: Co-CEO & Pre..
Common Stock 184,430 $0.97 $178,897
Purchase
DUGGAN ROBERT W director, officer: Chief Execut..
Common Stock 94,849,203 $0.97 $92,003,727
Purchase
ZANGANEH MAKY director, officer: Co-CEO & Pre..
Common Stock 1,030,925 $0.97 $999,997
Purchase
ZANGANEH MAKY director, officer: Chief Operat..
Common Stock 389,077 $5.24 $2,038,763
Purchase
DUGGAN ROBERT W director, 10 percent owner, off..
Common Stock 11,365,921 N/A N/A
Sale
POWELL DAVID JONATHAN officer: Chief Scientific Officer
Common Stock 13,713 N/A N/A
Option
POWELL DAVID JONATHAN officer: Chief Scientific Officer
Common Stock 13,713 N/A N/A
Sale
POWELL DAVID JONATHAN officer: Chief Scientific Officer
Common Stock 29,569 N/A N/A
Option
POWELL DAVID JONATHAN officer: Chief Scientific Officer
Common Stock 29,569 N/A N/A
Option
POWELL DAVID JONATHAN officer: Chief Scientific Officer
Common Stock 29,569 $1.86 $54,850
Sale
POWELL DAVID JONATHAN officer: Chief Scientific Officer
Common Stock 12,070 N/A N/A
Option
POWELL DAVID JONATHAN officer: Chief Scientific Officer
Common Stock 12,070 N/A N/A
Sale
POWELL DAVID JONATHAN officer: Chief Scientific Officer
Common Stock 11,374 N/A N/A
Option
POWELL DAVID JONATHAN officer: Chief Scientific Officer
Common Stock 11,374 N/A N/A
Option
POWELL DAVID JONATHAN officer: Chief Scientific Officer
Common Stock 6,987 N/A N/A
Sale
POWELL DAVID JONATHAN officer: Chief Scientific Officer
Common Stock 6,987 N/A N/A
Purchase
DUGGAN ROBERT W director, 10 percent owner, off..
Common Stock 14,071,856 N/A N/A

Showing 1 to 34 of 34 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.